科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/07/24 | 4,038 | 4,081 | 4,013 | 4,021 | -7 | -0.2% | 85,500 |
2024/07/23 | 4,010 | 4,038 | 3,980 | 4,028 | -10 | -0.2% | 120,300 |
2024/07/22 | 4,116 | 4,117 | 4,023 | 4,038 | -57 | -1.4% | 102,800 |
2024/07/19 | 4,157 | 4,157 | 4,059 | 4,095 | -91 | -2.2% | 146,400 |
2024/07/18 | 4,102 | 4,217 | 4,088 | 4,186 | +112 | +2.7% | 235,500 |
2024/07/17 | 4,086 | 4,111 | 4,074 | 4,074 | -5 | -0.1% | 103,100 |
2024/07/16 | 4,100 | 4,149 | 4,075 | 4,079 | +21 | +0.5% | 149,000 |
2024/07/12 | 3,995 | 4,073 | 3,995 | 4,058 | +46 | +1.1% | 137,700 |
2024/07/11 | 3,980 | 4,013 | 3,977 | 4,012 | +52 | +1.3% | 99,700 |
2024/07/10 | 3,967 | 3,987 | 3,940 | 3,960 | +1 | ±0% | 125,600 |
2024/07/09 | 3,950 | 3,994 | 3,950 | 3,959 | +15 | +0.4% | 107,600 |
2024/07/08 | 3,950 | 4,059 | 3,929 | 3,944 | +16 | +0.4% | 207,700 |
2024/07/05 | 3,899 | 3,928 | 3,883 | 3,928 | +42 | +1.1% | 114,300 |
2024/07/04 | 3,863 | 3,922 | 3,850 | 3,886 | +22 | +0.6% | 114,700 |
2024/07/03 | 3,817 | 3,878 | 3,802 | 3,864 | +43 | +1.1% | 120,100 |
2024/07/02 | 3,854 | 3,866 | 3,809 | 3,821 | -34 | -0.9% | 133,900 |
2024/07/01 | 3,845 | 3,900 | 3,842 | 3,855 | +5 | +0.1% | 147,800 |
2024/06/28 | 3,858 | 3,879 | 3,811 | 3,850 | +4 | +0.1% | 165,900 |
2024/06/27 | 3,830 | 3,881 | 3,811 | 3,846 | +22 | +0.6% | 210,900 |
2024/06/26 | 3,798 | 3,829 | 3,786 | 3,824 | +24 | +0.6% | 111,200 |
2024/06/25 | 3,800 | 3,830 | 3,794 | 3,800 | +9 | +0.2% | 86,400 |
2024/06/24 | 3,779 | 3,812 | 3,778 | 3,791 | +13 | +0.3% | 137,000 |
2024/06/21 | 3,796 | 3,829 | 3,775 | 3,778 | -21 | -0.6% | 225,500 |
2024/06/20 | 3,772 | 3,810 | 3,765 | 3,799 | +5 | +0.1% | 158,300 |
2024/06/19 | 3,712 | 3,838 | 3,712 | 3,794 | +74 | +2% | 179,000 |
2024/06/18 | 3,754 | 3,764 | 3,716 | 3,720 | -36 | -1% | 82,300 |
2024/06/17 | 3,767 | 3,780 | 3,715 | 3,756 | -9 | -0.2% | 129,500 |
2024/06/14 | 3,720 | 3,769 | 3,716 | 3,765 | +32 | +0.9% | 138,600 |
2024/06/13 | 3,784 | 3,784 | 3,725 | 3,733 | -57 | -1.5% | 96,600 |
2024/06/12 | 3,823 | 3,826 | 3,790 | 3,790 | -1 | ±0% | 102,700 |
2024/06/11 | 3,810 | 3,820 | 3,791 | 3,791 | -15 | -0.4% | 73,400 |
2024/06/10 | 3,795 | 3,823 | 3,770 | 3,806 | -17 | -0.4% | 119,000 |
2024/06/07 | 3,824 | 3,842 | 3,806 | 3,823 | -20 | -0.5% | 171,200 |
2024/06/06 | 3,925 | 3,985 | 3,821 | 3,843 | -12 | -0.3% | 363,000 |
2024/06/05 | 3,722 | 3,855 | 3,693 | 3,855 | +94 | +2.5% | 455,000 |
2024/06/04 | 3,788 | 3,827 | 3,636 | 3,761 | -27 | -0.7% | 555,500 |
2024/06/03 | 3,667 | 3,874 | 3,646 | 3,788 | +213 | +6% | 662,700 |
2024/05/31 | 3,662 | 3,674 | 3,534 | 3,575 | -91 | -2.5% | 401,200 |
2024/05/30 | 3,590 | 3,680 | 3,570 | 3,666 | +47 | +1.3% | 385,700 |
2024/05/29 | 3,584 | 3,645 | 3,540 | 3,619 | +175 | +5.1% | 427,500 |
2024/05/28 | 3,460 | 3,463 | 3,444 | 3,444 | -24 | -0.7% | 87,800 |
2024/05/27 | 3,452 | 3,468 | 3,441 | 3,468 | +6 | +0.2% | 85,300 |
2024/05/24 | 3,438 | 3,462 | 3,431 | 3,462 | +24 | +0.7% | 73,100 |
2024/05/23 | 3,415 | 3,450 | 3,406 | 3,438 | +30 | +0.9% | 70,800 |
2024/05/22 | 3,427 | 3,431 | 3,407 | 3,408 | -28 | -0.8% | 89,000 |
2024/05/21 | 3,439 | 3,481 | 3,436 | 3,436 | -4 | -0.1% | 127,000 |
2024/05/20 | 3,439 | 3,455 | 3,416 | 3,440 | -11 | -0.3% | 102,000 |
2024/05/17 | 3,426 | 3,455 | 3,416 | 3,451 | +8 | +0.2% | 115,300 |
2024/05/16 | 3,383 | 3,443 | 3,378 | 3,443 | +61 | +1.8% | 119,000 |
2024/05/15 | 3,473 | 3,473 | 3,378 | 3,382 | -101 | -2.9% | 249,800 |
251~
300
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 398,400円 | -6.4% | -71.8% | 4.77% | 44.50倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 440,500円 | +3.6% | - | 2.72% | 14.85倍 | 0.87倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 336,500円 | +7.9% | -3.3% | 2.38% | 9.36倍 | 0.97倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
サンバイオ | 236,000円 | - | - | 0.00% | - | 109.31倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム